artenimol has been researched along with Metastase in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (88.89) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, BM; Han, XL; Li, YT; Sun, YC; Tang, L; Yuan, LX | 1 |
| Gong, W; Hu, Y; Jiang, L; Li, H; Liang, H; Liu, Y; Ma, Q; Wang, X; Wang, Z; Xiang, S; Xu, Z; Ye, Y; Zhang, F; Zhang, Y | 1 |
| Chao, JP; Cheng, L; Ju, RJ; Li, CQ; Li, XT; Liu, S; Peng, XM; Song, XL; Wang, T | 1 |
| Cai, FY; Fu, M; Gong, XQ; Jing, M; Ju, RJ; Kong, L; Li, XT; Liu, JJ; Tang, W; Yao, XM | 1 |
| Hu, M; Li, F; Liu, W; Liu, Y; Liu, Z; Lu, L; Ou, R; Tong, Y; Wu, J; Zhang, G; Zheng, H; Zheng, L | 1 |
| An, H; Cai, C; Gao, J; Geng, G; Jiang, J; Li, N; Liu, H; Mi, Y; Shen, D; Wu, X; Yang, S; Yu, X; Zheng, L | 1 |
| Ba, Q; Chen, K; Chen, T; Li, J; Li, X; Liu, H; Liu, Y; Wang, H; Zhang, X; Zhou, Y | 1 |
| Li, A; Lou, XE; Wang, Z; Zhang, JL; Zhou, HJ | 1 |
| Azimian, S; Bair, WB; Cabello, CM; Lamore, SD; Lesson, JL; Qiao, S; Wondrak, GT | 1 |
9 other study(ies) available for artenimol and Metastase
| Article | Year |
|---|---|
[Preliminary study of dihydroartemisin in inhibiting invasion and metastasis of hepatoma cells].
Topics: Artemisinins; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; ErbB Receptors; Humans; Liver Neoplasms; Neoplasm Invasiveness; Neoplasm Metastasis; Signal Transduction | 2020 |
Dihydroartemisinin inhibits TCTP-dependent metastasis in gallbladder cancer.
Topics: Animals; Antineoplastic Agents; Artemisinins; Biomarkers, Tumor; cdc42 GTP-Binding Protein; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Female; Gallbladder Neoplasms; Heterografts; Humans; Mice; Neoplasm Metastasis; Neoplasm Staging; Tumor Protein, Translationally-Controlled 1 | 2017 |
Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer.
Topics: Ammonium Sulfate; Animals; Artemisinins; Biological Transport; Breast Neoplasms; Cell Movement; Daunorubicin; Humans; Lipid Bilayers; Liposomes; MCF-7 Cells; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Octreotide; Polyethylene Glycols; Wound Healing; Xenograft Model Antitumor Assays | 2018 |
Development of R
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Biological Transport; Carcinoma, Non-Small-Cell Lung; Cell Adhesion; Drug Liberation; Epirubicin; Humans; Lipid Bilayers; Liposomes; Lung Neoplasms; Mice; Neoplasm Invasiveness; Neoplasm Metastasis; Polyethylene Glycols; Xenograft Model Antitumor Assays | 2019 |
Artemisinin and its derivatives can significantly inhibit lung tumorigenesis and tumor metastasis through Wnt/β-catenin signaling.
Topics: A549 Cells; Animals; Antimalarials; Artemisinins; Artesunate; beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Female; Humans; Lung Neoplasms; Mice, Inbred BALB C; Mice, Nude; Neoplasm Metastasis; RNA Interference; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |
Repurposing the anti-malarial drug dihydroartemisinin suppresses metastasis of non-small-cell lung cancer via inhibiting NF-κB/GLUT1 axis.
Topics: Animals; Antimalarials; Artemisinins; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Female; Glucose Transporter Type 1; Humans; Lung Neoplasms; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Neoplasm Metastasis; NF-kappa B | 2016 |
Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Artemisinins; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; Drug Combinations; Drug Evaluation, Preclinical; Epithelial-Mesenchymal Transition; Female; Humans; Mice; Neoplasm Metastasis; Neoplasm Staging; Ovarian Neoplasms; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2016 |
Dihydroartemisinin improves the efficiency of chemotherapeutics in lung carcinomas in vivo and inhibits murine Lewis lung carcinoma cell line growth in vitro.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Artemisinins; Carcinoma, Lewis Lung; Cell Cycle; Cell Proliferation; Cell Survival; Cisplatin; Cyclophosphamide; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Random Allocation; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2010 |
The redox antimalarial dihydroartemisinin targets human metastatic melanoma cells but not primary melanocytes with induction of NOXA-dependent apoptosis.
Topics: Antimalarials; Antioxidants; Apoptosis; Artemisinins; Caspase 3; Cells, Cultured; Cytoprotection; DNA Damage; Drug Screening Assays, Antitumor; Enzyme Activation; Epidermis; Gene Expression Regulation, Neoplastic; Genome, Human; Humans; Iron Chelating Agents; Melanocytes; Melanoma; Mitochondria; Neoplasm Metastasis; Oligonucleotide Array Sequence Analysis; Oxidation-Reduction; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-bcl-2; Tumor Suppressor Protein p53; Up-Regulation | 2012 |